Form 4 for CYTK CYTOKINETICS INC
Accepted 2022-04-07 00:00:00 ET · period of report 2022-04-07 · accession 0001061983-22-000097 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-07 | 2022-04-07 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $42.58 | -23.1K | 168.1K | -12% | -$985.6K |
| D | 2022-04-07 | 2022-04-07 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $6.00 | +23.1K | 191.2K | +14% | +$138.9K |
| D | 2022-04-07 | 2022-04-07 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $0.00 | -23.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-07 | S | D | 23,148 | $42.58 | 168,084 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-07 | M | A | 23,148 | $6.00 | 191,232 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-04-07 | M | D | 23,148 | $0.00 | 0 | D | $6.00 · 2013-04-05 to 2023-03-05 | 23,148 Common Stock |